Page last updated: 2024-08-24

5-methylcytosine and Testicular Neoplasms

5-methylcytosine has been researched along with Testicular Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cen, X; Ou, J; Shen, Y; Wang, B; Wang, L1
Amouroux, R; Benešová, M; Hajkova, P; Hejnar, J; Hron, T; Klézl, P; Kučerová, D; Szabó, A; Trejbalová, K; Vernerová, Z1

Other Studies

2 other study(ies) available for 5-methylcytosine and Testicular Neoplasms

ArticleYear
Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
    International journal of medical sciences, 2022, Volume: 19, Issue:2

    Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Testicular Neoplasms; Testis

2022
Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:8

    Topics: 5-Methylcytosine; Adult; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Male; Mixed Function Oxygenases; Proto-Oncogene Proteins; Seminoma; Testicular Neoplasms; Testis; Up-Regulation

2017